Publication:
Corrigendum to “Strength in synergy: Cardiometabolic effects of sacubitril/valsartan in heart failure and diabetes” [International Journal of Cardiology 2023 Jan 15;371:293–294 10.1016/j.ijcard.2022.09.019 (International Journal of Cardiology (2023) 371 (293–294), (S0167527322013286), (10.1016/j.ijcard.2022.09.019))

dc.contributor.authorSeferović, Petar M. (6603594879)
dc.contributor.authorPolovina, Marija (35273422300)
dc.contributor.authorSeferović, Jelena (23486982900)
dc.contributor.authorRosano, Giuseppe (7007131876)
dc.date.accessioned2025-06-12T12:17:38Z
dc.date.available2025-06-12T12:17:38Z
dc.date.issued2023
dc.description.abstractThe authors regret the Funding section. The latter should read as follows: “This study was supported by the Italian Ministry of Health (Ricerca Corrente) 20/1819”. The authors would like to apologise for any inconvenience caused. © 2023 Elsevier B.V.
dc.identifier.urihttps://doi.org/10.1016/j.ijcard.2023.02.016
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85148371648&doi=10.1016%2fj.ijcard.2023.02.016&partnerID=40&md5=f9f98d3de64cafde65c682416c900f74
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/2781
dc.titleCorrigendum to “Strength in synergy: Cardiometabolic effects of sacubitril/valsartan in heart failure and diabetes” [International Journal of Cardiology 2023 Jan 15;371:293–294 10.1016/j.ijcard.2022.09.019 (International Journal of Cardiology (2023) 371 (293–294), (S0167527322013286), (10.1016/j.ijcard.2022.09.019))
dspace.entity.typePublication

Files